-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/advanced-care-decision-aids_technical-brief.pdf
July 01, 2014 - review the relevant scientific
literature on topics assigned to them by AHRQ and conduct additional analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
December 01, 2015 - No statistical analyses were reported.59,60
The most common adverse reactions occurring in patients
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
July 01, 2013 - measures of weight loss change from run-in compared to
placebo treatment (Table) (p<0.0001 in all analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
January 01, 2014 - because we restricted our parameters to only include clinical trials, systematic reviews,
and meta-analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/documentation-burden-prepub-disposition-comments.pdf
May 21, 2024 - Root cause
analyses such as VA-based study by L.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth-future_research.pdf
August 09, 2012 - review the relevant scientific
literature on topics assigned to them by AHRQ and conduct additional analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mrsa-screening_research.pdf
June 01, 2013 - review the relevant scientific
literature on topics assigned to them by AHRQ and conduct additional analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-e.xlsx
January 01, 2024 - Outcome Fiber Knots Alpha Beta (Before Knot) Beta (After Knot) Tau (95% CI) of intercepts, for Overall analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
May 01, 2022 - The decision to update meta-analyses from the original report was based on the number and
sample sizes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-e.xlsx
January 01, 2024 - Outcome Fiber Knots Alpha Beta (Before Knot) Beta (After Knot) Tau (95% CI) of Intercepts, for Overall Analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
September 01, 2014 - Study design Meta-analyses, systematic reviews, RCTs, and nonrandomized controlled
trials for each
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nursing-staff-shortages-rapid-research.pdf
April 01, 2025 - Shortages
across the week following emergency
admission to hospital: linked
retrospective observational analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_technical-brief.pdf
March 01, 2015 - review the relevant scientific
literature on topics assigned to them by AHRQ and conduct additional analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
April 01, 2013 - review the relevant scientific
literature on topics assigned to them by AHRQ and conduct additional analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pediatric-ehr_disposition-comments.pdf
May 01, 2015 - also are requested by health service researchers to
include family structure information in their analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_executive.pdf
January 01, 2010 - Subcutaneous
immunotherapy and pharmacotherapy in seasonal allergic rhinitis:
a comparison based on meta-analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - the manufacturer, the NDA
addresses questions raised in the FDA's letter and provides additional analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-appendix-c.xlsx
January 01, 2024 - List of Evidence Tables
Category Evidence table
Systematic Reviews Evidence Table C-1. Characteristics and findings of included systematic reviews
Primary studies: Study characteristics Evidence Table C-2. Study characteristics of included primary studies
Evidence Table C-3. Intervention characteristics of include…
-
effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - Fidaxomicin shows early superiority over
vancomycin on intention-to-treat analyses of
pivotal randomized
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
March 15, 2016 - perplexing that the authors don’t appear to
support a treat-to-target threshold, yet cite data from analyses